Ad:

Metformin reduces thromboembolic risk in patients with type 2 diabetes

lukasz Buldak, MD

You can read this text in 3 min.

Metformin reduces thromboembolic risk in patients with type 2 diabetes

Shutterstock

Sugar testing

Type 2 diabetes is a lifestyle disease affecting almost 500 million people. Numerous complications develop during its course. These include accelerated atherosclerosis, which leads to: heart attacks, strokes, damage to the kidneys, eyesight and nervous system. It has also been observed that type 2 diabetes increases the risk of thromboembolism by 42%.

Ad: